We are live on ! Find out more
HCA icon

HCA Healthcare

1,056 hedge funds and large institutions have $46.1B invested in HCA Healthcare in 2023 Q4 according to their latest regulatory filings, with 154 funds opening new positions, 333 increasing their positions, 423 reducing their positions, and 86 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more first-time investments, than exits

New positions opened: 154 | Existing positions closed: 86

35% more funds holding in top 10

Funds holding in top 10: 2635 (+9)

11% more capital invested

Capital invested by funds: $41.6B → $46.1B (+$4.49B)

6% more funds holding

Funds holding: 1,0001,056 (+56)

1.67% more ownership

Funds ownership: 61.97%63.64% (+1.7%)

17% less call options, than puts

Call options by funds: $558M | Put options by funds: $671M

21% less repeat investments, than reductions

Existing positions increased: 333 | Existing positions reduced: 423

Holders
1,056
Holders Change
+56
Holders Change %
+5.6%
% of All Funds
15.4%
Holding in Top 10
35
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+34.62%
% of All Funds
0.51%
New
154
Increased
333
Reduced
423
Closed
86
Calls
$558M
Puts
$671M
Net Calls
-$113M
Net Calls Change
-$49.9M
Name Holding Trade Value Shares
Change
Change in
Stake
IIM
176
INTECH Investment Management
Florida
$21.3M +$2.35M +9,492 +14%
Mercer Global Advisors
177
Mercer Global Advisors
Colorado
$20.9M +$731K +2,956 +4%
RC
178
RBF Capital
California
$20.3M
Connor, Clark & Lunn Investment Management (CC&L)
179
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$20.2M -$16.9M -68,315 -48%
AAMU
180
APG Asset Management US
New York
$20.1M +$18.4M +74,425 New
Zurich Cantonal Bank
181
Zurich Cantonal Bank
Switzerland
$19.8M -$1.55M -6,276 -8%
GF
182
Gabelli Funds
New York
$19.5M -$2.86M -11,585 -14%
8KM
183
8 Knots Management
Texas
$18.4M +$16.8M +67,863 New
Axa
184
Axa
France
$18.3M -$7.78M -31,477 -32%
WP
185
Woodline Partners
California
$18.1M +$16.5M +66,790 New
RG
186
Redmile Group
California
$17.9M +$10.2M +41,433 +168%
Nisa Investment Advisors
187
Nisa Investment Advisors
Missouri
$17.8M -$1.47M -5,960 -8%
DekaBank Deutsche Girozentrale
188
DekaBank Deutsche Girozentrale
Germany
$17.8M -$890K -3,601 -5%
D.E. Shaw & Co
189
D.E. Shaw & Co
New York
$17.6M +$11.3M +45,902 +238%
LC
190
Loews Corp
New York
$17.6M +$1.85M +7,500 +13%
FAF
191
Första AP-fonden
Sweden
$17.6M -$1.75M -7,100 -10%
Osaic Holdings
192
Osaic Holdings
Arizona
$17.3M -$7.09M -28,671 -31%
OSAM
193
O'Shaughnessy Asset Management
Connecticut
$17.3M -$972K -3,933 -6%
Stifel Financial
194
Stifel Financial
Missouri
$17.2M +$2.59M +10,491 +20%
Nomura Asset Management
195
Nomura Asset Management
Japan
$16.9M +$2.33M +9,411 +18%
IG
196
ING Group
Netherlands
$16.8M +$1.25M +5,048 +9%
WIC
197
Woodmont Investment Counsel
Tennessee
$16.4M +$309K +1,250 +2%
DnB Asset Management
198
DnB Asset Management
Norway
$16.4M +$1.85M +7,476 +14%
IB
199
Intrust Bank
Kansas
$16.4M -$32.1K -130 -0.2%
AIG
200
American International Group
New York
$16.3M -$220K -892 -1%

HCA Hedge Fund Activity: Q4 2023 in Review

1,056 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in HCA Healthcare (HCA) for Q4 2023, worth a combined $46.1B — up 11% from $41.6B a quarter earlier.

Buyers outnumbered sellers: 154 funds opened new HCA positions and 86 closed out — a net gain of 68 holders — while 333 added to existing stakes and 423 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $495M. The largest seller was JP Morgan Chase, cutting an estimated $470M.

  • 1,056 institutional investors held HCA Healthcare (HCA) as of Q4 2023, up from 1,000 in Q3 2023.
  • Funds reported $46.1B of HCA Healthcare stock for Q4 2023, up 11% quarter-over-quarter.
  • 154 funds opened new HCA Healthcare positions in Q4 2023 and 86 closed out, a net change of +68 holders.
  • The largest HCA Healthcare buyer in Q4 2023 was Morgan Stanley, an estimated $495M added.
  • The largest HCA Healthcare seller in Q4 2023 was JP Morgan Chase, an estimated $470M sold.

Based on aggregated 13F filings for Q4 2023.